Showing 161-180 of 498 for: Cochrane Systematic Reviews > Neurologic 
- Electromechanical‐assisted training for walking after stroke
Cochrane Systematic Reviews, 22-Oct-2020
Electromechanical- and robot-assisted gait-training devices are used in rehabilitation and might help to improve walking after stroke. This is an update of a Cochrane Review first published in 2007 and previously updated in 2017.
- EMG biofeedback for the recovery of motor function after stroke
Cochrane Systematic Reviews, 24-Aug-2008
Electromyographic biofeedback (EMG-BFB) is a technique that is believed to have additional benefit when used with standard physiotherapy for the recovery of motor function in stroke patients. However, evidence from individual trials and previous systemati
- Enhanced glucose control for preventing and treating diabetic neuropathy
Cochrane Systematic Reviews, 11-May-2012
There are two types of diabetes. Type 1 diabetes affects younger people and needs treatment with insulin injections. Type 2 diabetes affects older people and can usually be treated by diet and oral drugs. Diabetic neuropathy affects 10% of patients with d
- Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease
Cochrane Systematic Reviews, 19-Jan-2011
Enteral feeding (tube feeding) is offered to many people with amyotrophic lateral sclerosis/motor neuron disease experiencing difficulty swallowing (dysphagia) and maintaining adequate nutritional intake leading to weight loss.
- Enteral tube feeding for older people with advanced dementia
Cochrane Systematic Reviews, 15-Apr-2009
The use of enteral tube feeding for patients with advanced dementia who have poor nutritional intake is common. In one US survey 34% of 186,835 nursing home residents with advanced cognitive impairment were tube fed. Potential benefits or harms of this pr
- Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome)
Cochrane Systematic Reviews, 5-Feb-2016
Mucopolysaccharidosis II, also known as Hunter syndrome, is a rare, X-linked disease caused by a deficiency of the lysosomal enzyme iduronate-2-sulfatase, which catalyses a step in the catabolism of glycosaminoglycans. The glycosaminoglycans accumulate wi
- Epidural blood patching for preventing and treating post-dural puncture headache
Cochrane Systematic Reviews, 22-Nov-2013
This is an update of a Cochrane Review first published in Issue 2, 2002. Dural puncture is a common procedure, but leakage of cerebrospinal fluid (CSF) from the resulting dural defect may cause post-dural puncture headache (PDPH) after the procedure, and
- Epilepsy clinics versus general neurology or medical clinics
Cochrane Systematic Reviews, 25-Oct-2008
Epilepsy is the most common serious neurological condition after stroke, with a 0.5% prevalence, and a two to three per cent life time risk of being given a diagnosis of epilepsy in the developed world.
- Erythropoietin or darbepoetin for patients with cancer
Cochrane Systematic Reviews, 12-Dec-2012
Anaemia associated with cancer and cancer therapy is an important clinical factor in the treatment of malignant diseases. Therapeutic alternatives are recombinant human erythropoiesis stimulating agents (ESAs) and red blood cell transfusions.
- Eslicarbazepine acetate add‐on therapy for drug‐resistant focal epilepsy
Cochrane Systematic Reviews, 22-Jun-2021
This is an update of a review first published in 2011, and last updated in 2017.
- Ethamsylate for the prevention of morbidity and mortality in preterm or very low birth weight infants
Cochrane Systematic Reviews, 20-Jan-2010
Ethamsylate decreases blood loss in certain clinical situations such as menorrhagia and following some surgical procedures. This potential to reduce bleeding has led to the hypothesis that it may have a role to play in reducing intraventricular haemorrhag
- Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents
Cochrane Systematic Reviews, 21-Jan-2021
This is an updated version of the Cochrane Review previously published in 2019.
- Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson´s disease patients with motor complications
Cochrane Systematic Reviews, 17-Jun-2010
One of the complications of long-term treatment of Parkinson's disease (PD) with levodopa is the development of motor complications. Generally, when motor complications develop, clinicians add in an additional drug (to the levodopa regimen) from one of th
- Excitatory amino acid inhibitors for traumatic brain injury
Cochrane Systematic Reviews, 20-Jan-2003
Glutamate is the principal excitatory neurotransmitter in the brain. Injury to the brain can cause an ionic imbalance in cerebral tissue, creating an excitotoxic cascade involving glutamate and other excitatory amino acids, that leads to neuronal death in
- Exercise and mobilisation interventions for carpal tunnel syndrome
Cochrane Systematic Reviews, 3-May-2012
Non-surgical treatment, including exercises and mobilisation, has been offered to people experiencing mild to moderate symptoms arising from carpal tunnel syndrome (CTS). However, the effectiveness and duration of benefit from exercises and mobilisation f
- Exercise for people with peripheral neuropathy
Cochrane Systematic Reviews, 10-May-2011
Peripheral neuropathies are a wide range of diseases affecting the peripheral nerves. Demyelination or axonal degeneration gives rise to a variety of symptoms including reduced or altered sensation, pain, muscle weakness and fatigue. Secondary disability
- Exercise for the management of cancer‐related fatigue in adults
Cochrane Systematic Reviews, 14-Nov-2012
Cancer-related fatigue is recognised as an important symptom associated with cancer and its treatment. A number of studies have investigated the effects of physical activity in reducing cancer-related fatigue. This is an updated version of the original Co
- Exercise therapy for chronic fatigue syndrome
Cochrane Systematic Reviews, 2-Oct-2019
Chronic fatigue syndrome (CFS) or myalgic encephalomyelitis (ME) is a serious disorder characterised by persistent postexertional fatigue and substantial symptoms related to cognitive, immune and autonomous dysfunction. There is no specific diagnostic tes
- Exercise therapy for multiple sclerosis
Cochrane Systematic Reviews, 24-Jan-2005
No intervention has proven effective in modifying long-term disease prognosis in Multiple Sclerosis (MS) but exercise therapy is considered to be an important part of symptomatic and supportive treatment for these patients.
- Family therapy for attention-deficit disorder or attention-deficit/hyperactivity disorder in children and adolescents
Cochrane Systematic Reviews, 16-Feb-2010
Attention-deficit hyperactivity disorder (ADHD) is diagnosed in between 3% and 7% of school-age children and consists of the core symptoms of inattention, impulsivity and hyperactivity. Children are often treated with medication, usually stimulant medicat
